ulcerative colitis

PTH-099 A novel approach to the implementation of biosimilar infliximab ct-p13 for the treatment of ibd utilising therapeutic drug monitoring: the edinburgh experience
N Plevris, TA Manship, A Deekae, GR Jones, CL Noble, J Satsangi, AG Shand, ID Arnott, CW Lees

Gut Jul 2017, 66 (Suppl 2) A255-A257; DOI: 10.1136/gutjnl-2017-314472.498
PTH-102 Association of gut microbiota with mucosal inflammation in ulcerative colitis
MN Quraishi, A Rossiter, B Chung, M Beaumont, E Liaskou, R Horniblow, A Beggs, D Withers, S Ghosh, C Tselepis, G Hirschfield, T Iqbal

Gut Jul 2017, 66 (Suppl 2) A257; DOI: 10.1136/gutjnl-2017-314472.501
PTH-106 Phenotypic characterisation of elderly – onset inflammatory bowel disease – ibd at 60 and beyond
U Nosegbe, B Miller, B Crooks, J Scott, J Limdi

Gut Jul 2017, 66 (Suppl 2) A258-A260; DOI: 10.1136/gutjnl-2017-314472.505
PTH-112 Assessing the effect of ethnicity on urinary metabolic profiles in inflammatory bowel disease
LC Hicks, STR Powles, LWL Chong, J Swann, E Holmes, HRT Williams, TR Orchard

Gut Jul 2017, 66 (Suppl 2) A261-A263; DOI: 10.1136/gutjnl-2017-314472.511
PTH-056 Effects of time on urinary metabolic signatures in inflammatory bowel disease
LC Hicks, STR Powles, LWL Chong, J Swann, E Holmes, HRT Williams, TR Orchard

Gut Jul 2017, 66 (Suppl 2) A233-A234; DOI: 10.1136/gutjnl-2017-314472.455
PTH-058 Golimumab: early experience and medium-term outcomes from two uk tertiary ibd centres
MA Samaan, P Pavlidis, AO Akintimehi, L Medcalf, G Chung-Faye, P Dubois, I Koumoutsos, S Anderson, J Sanderson, BH Hayee, PM Irving

Gut Jul 2017, 66 (Suppl 2) A234-A236; DOI: 10.1136/gutjnl-2017-314472.457
PTH-066 Post-marketing experience of vedolizumab: pneumonia and other respiratory tract infections
F Bhayat, A Blake, SP Travis

Gut Jul 2017, 66 (Suppl 2) A238-A239; DOI: 10.1136/gutjnl-2017-314472.465
PTH-067 Incidence of pneumonia and other respiratory tract infections with vedolizumab treatment: clinical trial experience
BG Feagan, F Bhayat, JM Khalid, W Palo, A Blake, M Shetzline, SP Travis

Gut Jul 2017, 66 (Suppl 2) A239-A240; DOI: 10.1136/gutjnl-2017-314472.466
PTH-068 Tuberculosis in patients treated with vedolizumab: clinical trial and post-marketing case series
M Zerôncio, A Blake, Q Rana-Khan, W Palo, F Bhayat

Gut Jul 2017, 66 (Suppl 2) A240; DOI: 10.1136/gutjnl-2017-314472.467
AODTH-003 Vedolizumab clinical and post-marketing safety experience of opportunistic infections
SC Ng, W Palo, A Blake, Q Rana-Khan, F Bhayat

Gut Jul 2017, 66 (Suppl 2) A200; DOI: 10.1136/gutjnl-2017-314472.390

Main menu

ulcerative colitis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

ulcerative colitis

Pages